Business Context and Reporting Period
This Form 6-K filing by Ambev S.A. reports on corporate actions and treasury transactions for the month of October 2016, filed on November 10, 2016. The document details compliance with Article 11 of CVM Instruction # 358/2002 regarding securities and derivatives operations.
Key Financial Metrics and Transactions
The filing focuses on treasury share movements and ADR conversions rather than operational financial performance. Key transaction volumes include:
- Treasury Shares (Common): Initial balance of 18,021,650 shares; Final balance of 17,925,223 shares.
- Share Sales: 24,827 deferred shares sold for a total volume of R$ 108,280.08.
- ADR Conversions: 71,600 common shares converted into ADRs (outflow from treasury).
- ADR Acquisitions: 108,375 ADRs purchased under a share acquisition plan for a total volume of $640,960.61 USD.
- Option Exercises: 179,975 ADRs sold via option exercises for a total volume of $645,301.47 USD.
Material Changes
The primary material change is the reduction in the company's treasury share count by 96,427 shares during the reporting month. This reduction resulted from the conversion of shares into ADRs and the sale of deferred shares. The filing does not provide comparative data for the prior period to assess year-over-year changes.
Guidance, Outlook, and Risks
The filing text does not provide management commentary, financial guidance, outlook, or specific risk factors. It is a regulatory disclosure of specific securities transactions and does not contain unusual items or contingencies beyond the reported treasury activities.
Investor Verification Checklist
- Verify the impact of the 96,427 share reduction on total outstanding shares and earnings per share.
- Confirm the pricing details of the 108,375 ADRs acquired under the share acquisition plan.
- Review the terms of the options exercised totaling 179,975 ADRs to understand the dilution or capital raise implications.
- Note that this filing contains no operational revenue or profit data; refer to the annual 20-F for full financial statements.